IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2019 Holdings

Filed 2020-02-14 | 13 holdings | $191.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$190.8M643,00099.4%
Medicines CoCOM584688105$356.9K4,202,0000.2%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$137.2K10,307,0000.1%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$106.6K860,0000.1%
Allergan PLCSHSG0177J108$89.4K467,5000.0%
Innoviva Inc(INVA)COM45781M101$88.4K6,242,0000.0%
Abbvie Inc(ABBV)COM00287Y109$88.0K1,0000.0%
Alkermes PLC(ALKS)SHSG01767105$77.6K3,805,0000.0%
Medicines CoNOTE 3.500% 1/1584688AJ4$68.4K$20,000,0000.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$66.2K443,5000.0%
Mersana Therapeutics IncCOM59045L106$21.5K3,750,0000.0%
Regulus Therapeutics IncCOM NEW75915K200$1.6K1,851,8510.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$1281,0000.0%